![Responsiveness of Different Dynamic Contrast-enhanced Magnetic Resonance Imaging Approaches: a Post-hoc Analysis of a Randomized Controlled Trial of Certolizumab Pegol in Rheumatoid Arthritis](http://www.ia-grp.com/wp-content/plugins/revslider/public/assets/assets/transparent.png)
![](http://www.ia-grp.com/wp-content/uploads/2017/07/ORANGE-SLIDER-SHAPE-1.1.png)
Responsiveness of Different Dynamic Contrast-enhanced Magnetic Resonance Imaging Approaches: a Post-hoc Analysis of a Randomized Controlled Trial of Certolizumab Pegol in Rheumatoid Arthritis
Published:
July 24, 2020
Publication:
Scandinavian Journal of Rheumatology
Authors:
MB Axelsen, M Boesen, H Bliddal, LTH Jacobsson, MS Hansen, M Østergaard